BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17233385)

  • 1. [Evaluation of FDG-PET imaging for the detection of gastrointestinal tract cancer in patients with suspected lung cancer].
    Uesaka D; Demura Y; Umeda Y; Morikawa M; Nakanishi M; Kadowaki M; Mizuno S; Ameshima S; Miyamori I; Sasaki M; Ishizaki T
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):899-905. PubMed ID: 17233385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer].
    Isobe K; Hata Y; Sakaguchi S; Takai Y; Shibuya K; Takagi K; Homma S
    Nihon Kokyuki Gakkai Zasshi; 2010 Jul; 48(7):482-7. PubMed ID: 20684209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis of the gastrointestinal tract: FDG-PET imaging.
    Hayasaka K; Nihashi T; Matsuura T; Yagi T; Nakashima K; Kawabata Y; Ito K; Katoh T; Sakata K; Harada A
    Ann Nucl Med; 2007 Aug; 21(6):361-5. PubMed ID: 17705017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
    Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
    Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
    Hsieh TC; Wu YC; Ding HJ; Wang CH; Yen KY; Sun SS; Yeh JJ; Kao CH
    Eur J Radiol; 2011 Dec; 80(3):e510-5. PubMed ID: 21439750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.
    van Westreenen HL; Westerterp M; Jager PL; van Dullemen HM; Sloof GW; Comans EF; van Lanschot JJ; Wiggers T; Plukker JT
    J Nucl Med; 2005 Aug; 46(8):1321-5. PubMed ID: 16085589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
    Buchmann I; Ganten TM; Haberkorn U
    Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
    J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
    Kamel EM; Thumshirn M; Truninger K; Schiesser M; Fried M; Padberg B; Schneiter D; Stoeckli SJ; von Schulthess GK; Stumpe KD
    J Nucl Med; 2004 Nov; 45(11):1804-10. PubMed ID: 15534047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A colon adenocarcinoma and a pharyngeal carcinoma incidentally detected by means of (18)F-FDG PET in a patient diagnosed of lung cancer].
    Caballero Gullón L; Borrego Dorado I; Vázquez Albertino R
    Rev Esp Med Nucl; 2010; 29(1):29-31. PubMed ID: 19969392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
    Lonneux M; Delval D; Bausart R; Moens R; Willockx R; Van Mael P; Declerck P; Jamar F; Zreik H; Pauwels S
    Nucl Med Commun; 1998 Nov; 19(11):1047-54. PubMed ID: 9861621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma.
    Zhang Y; Li G; Zhuang H
    Clin Nucl Med; 2008 Feb; 33(2):109-10. PubMed ID: 18209530
    [No Abstract]   [Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
    Zhao DS; Valdivia AY; Li Y; Blaufox MD
    Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
    J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
    Liu SW; Yu JM; Xing LG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):626-9. PubMed ID: 15634527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.